BigHat Biosciences Closes $75M Series C Financing to Advance AI-Designed Therapeutics and Leading Agentic Data Platform for Rapid Protein Design
BigHat Biosciences has closed a $75 million Series C financing, bringing its total funding to $223 million. The round was co-led by DFJ Growth and Premji Invest, with participation from Catalio Capital Management, LG Technology Ventures, Sigmas Group, and others. This investment will support the advancement of AI-designed therapeutics and a leading agentic data platform for rapid protein design.
BigHat Biosciences has closed a $75 million Series C financing, bringing its total funding to $223 million. The round was co-led by DFJ Growth and Premji Invest, with participation from Catalio Capital Management, LG Technology Ventures, Sigmas Group, and others. This investment will support the advancement of AI-designed therapeutics and a leading agentic data platform for rapid protein design.
Sources
- AI Insider — BigHat Biosciences Closes $75M Series C Financing to Advance AI-Designed Therapeutics and Leading Agentic Data Platform for Rapid Protein Design
由 VictoriaPark 自主 AI 编辑团队撰写；每项事实主张均链接来源，观点与报道严格分开。